Cargando…

Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies

A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jaydeep, Kevin, Garala, Patel, Anjali, Raval, Mihir, Sheth, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658033/
https://www.ncbi.nlm.nih.gov/pubmed/23781428
http://dx.doi.org/10.4103/2229-4708.81092
_version_ 1782270212175822848
author Patel, Jaydeep
Kevin, Garala
Patel, Anjali
Raval, Mihir
Sheth, Navin
author_facet Patel, Jaydeep
Kevin, Garala
Patel, Anjali
Raval, Mihir
Sheth, Navin
author_sort Patel, Jaydeep
collection PubMed
description A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions recommended by the International Conference on Harmonization (ICH). The samples so generated were used for degradation studies using the developed method. The λ(max) of the OLM was found to be 257 nm. The method exhibited high sensitivity, with linearity, in the 2 to 20 μg/ml range. The lower limit of detection and the limit of quantification were found to be 1.012 μg/ml and 3.036 μg/ml, respectively. All the calibration curves demonstrated a linear relationship between the absorbance and concentration, with the correlation coefficient higher than 0.99. The regression equation of the curve was Y = 0.0579x + 0.0006. The precision of the method was found to be 40.043 ± 0.067 against the label claim of 40 mg. The percentage recovery was found to be 101.32 ± 0.452. The sample solution was stable for up to two hours. Hence, it could be concluded that the proposed method would be suitable for the analysis of OLM in bulk and pharmaceutical formulations.
format Online
Article
Text
id pubmed-3658033
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36580332013-06-18 Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies Patel, Jaydeep Kevin, Garala Patel, Anjali Raval, Mihir Sheth, Navin Pharm Methods Original Article A simple, sensitive, specific, spectrophotometric method was developed for the detection of Olmesartan medoxomil (OLM) in bulk and pharmaceutical formulations. The optimum conditions for the analysis of the drug were established. OLM was subjected to stress degradation under different conditions recommended by the International Conference on Harmonization (ICH). The samples so generated were used for degradation studies using the developed method. The λ(max) of the OLM was found to be 257 nm. The method exhibited high sensitivity, with linearity, in the 2 to 20 μg/ml range. The lower limit of detection and the limit of quantification were found to be 1.012 μg/ml and 3.036 μg/ml, respectively. All the calibration curves demonstrated a linear relationship between the absorbance and concentration, with the correlation coefficient higher than 0.99. The regression equation of the curve was Y = 0.0579x + 0.0006. The precision of the method was found to be 40.043 ± 0.067 against the label claim of 40 mg. The percentage recovery was found to be 101.32 ± 0.452. The sample solution was stable for up to two hours. Hence, it could be concluded that the proposed method would be suitable for the analysis of OLM in bulk and pharmaceutical formulations. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3658033/ /pubmed/23781428 http://dx.doi.org/10.4103/2229-4708.81092 Text en Copyright: © Pharmaceutical Methods http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Patel, Jaydeep
Kevin, Garala
Patel, Anjali
Raval, Mihir
Sheth, Navin
Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title_full Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title_fullStr Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title_full_unstemmed Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title_short Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
title_sort development of the uv spectrophotometric method of olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658033/
https://www.ncbi.nlm.nih.gov/pubmed/23781428
http://dx.doi.org/10.4103/2229-4708.81092
work_keys_str_mv AT pateljaydeep developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies
AT kevingarala developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies
AT patelanjali developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies
AT ravalmihir developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies
AT shethnavin developmentoftheuvspectrophotometricmethodofolmesartanmedoxomilinbulkdrugandpharmaceuticalformulationandstressdegradationstudies